Economic & Market Data

As a Merrill Edge client, you can access award-winning BofA Merrill Lynch Global Research and independent, third-party insights to help you make more informed investment decisions.1


Today's Market Summary

As of 9/22/2017 5:59 PM ET
Provided by: Thomson Reuters

The Dow Jones Industrial Average ended little changed today. The Real Estate and Utilities sectors were the biggest laggards, down 0.82% and 0.43% respectively.

Stay updated by tracking the highest volume gainers and losers throughout the day.

Today's Market News

Bristol-Myers Squibb’s Opdivo® (nivolumab) Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib
4 minutes agoBusiness Wire

Opdivo is the first and only Immuno-Oncology agent to receive this FDA approval; this accelerated approval is based on tumor response rate and durability of response in these patients The CheckMate -040 pivotal study evaluated Opdivo in patients with and without active Hepatitis B or C infection, and across PD-L1 expression levels 1,2 HCC is the most common type of liver cancer and incidence rates are increasing 3,4. PRINCETON, N.J.---- Bristol-Myers Squibb Company today...

Read More »

Related Investments

Bristol-Myers Squibb Co

Last 3 Months
Genesis Research and Technology Group Unveils Investment Grade Water on the Blockchain
14 minutes agoPR Newswire
Western Union Supports Mexico Earthquake Relief Efforts
15 minutes agoBusiness Wire
ACLA Expresses Serious Concerns with Proposed PAMA Medicare Payment Rates for Clinical Laboratory Tests; Renews Call for Delay and Reform
26 minutes agoPR Newswire
University of Colorado at Boulder Wins Tech Accelerator of the Year at FSTEC
27 minutes agoPR Newswire
Doors'N'More Recently Completed a Rebranding, Highlighting a New Sleek Modern Design
29 minutes agoPR Newswire

Today's IndicesAs of 4:41pm ET 09/22/2017

IndexLastToday's Change
Dow Jones22,349.59-9.64-0.04%
S&P 500 Index2,502.221.620.06%
NASDAQ Composi...6,426.924.230.07%

Click a check box to add an index to the chart.

More features & benefits

Global Markets

Global Markets

Access global headlines and international research to help you make better decisions.

Market Charting

Market Charting

Track performance of global indices, foreign exchanges, key rates.


Calendar & News

Breaking news helps you gain greater perspective on pursuing your goals.

You might also be interested in..

Independent research

Independent research

Third-party research, timely news feeds and advanced online capabilities. Learn more

Timely, insightful webcasts

View webcasts

Watch Merrill Lynch and industry leaders discuss timely investment topics.
View webcasts

Ready to get started?

Open An Account 888.637.3343

Find a Financial Solutions Advisor

Schedule a consultation

Institutional Investor magazine announced BofA Merrill Lynch Global Research as the Top Global Research Firm for 2011-2016 based on surveys held throughout the year. The magazine creates rankings of the top research analysts in a wide variety of specializations, drawn from the choices of portfolio managers and other investment professionals at more than 1,000 firms. For more information about this award, go to
While we believe our pricing information to be reliable, we cannot guarantee its accuracy.

Any pricing and other information relating to a security or securities is provided on a delayed basis, not on a real-time basis.

Sector Classifications based on Global Industry Classification Standard ("GICS").

®Thomson Reuters 2014. All rights reserved. Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited without the prior written consent of Thomson Reuters. 'Thomson Reuters' and the Thomson Reuters logo are registered trademarks and trademarks of Thomson Reuters and its affiliated companies.